The path to IPO has become slower and more arduous for companies looking for an exit, writes Fiunder Shield's COO Carl ...

HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multi ...

Guming says it targets smaller cities where bubble tea is not as readily available and growth outpaces that of megacities.

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...